Hims vs PeterMD: Which GLP-1 Provider Is Better?
Short answer: Hims scores higher on our rubric, 7.9/10 against 7.3/10. Full reasoning, pricing and the cases where the other one wins are below.
Hims beats PeterMD overall, scoring 7.9/10 vs 7.3/10. Published pricing is not a like-for-like monthly comparison: Hims is $188 first month, then $298/mo; PeterMD is from $165/mo. Choose Hims for men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership, but should know going in that hims' customer-experience signal is weaker than smaller competitors. Choose PeterMD for budget-conscious users looking for the lowest monthly glp-1 cost.
A side-by-side look at Hims and PeterMD to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Hims
#7 of 54The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy, Ozempic, Foundayo, and Zepbound paths and has since exited compounded semaglutide for new retail patients. The advertised medication floor is $149, but the required Weight Loss Membership adds $39 in month one and $149/month after that, so the all-in floor is $188 initially and $298 ongoing before any product- or dose-specific increase. Its parent still reports offering access to compounded GLP-1 medications on a limited scale (Q2 2026 results, filed with the SEC August 10, 2026). Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026), significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28%, the highest 1-star rate in our table, clustered around subscription/billing complaints.
Visit HimsPeterMD
#28 of 54One of the most affordable compounded GLP-1 options on the market, ideal for budget-conscious patients.
Visit PeterMD| Feature | Hims | PeterMD |
|---|---|---|
| Why each one | The only publicly-traded men's telehealth (NYSE: HIMS) with FDA-approved Wegovy via direct Novo Nordisk partnership. Brand-name access plus SEC accountability, but balanced against a 3.0 Trustpilot rating that lags peers. | Flat $165/mo pricing at all doses with semaglutide + B12 formulation (B12 helps reduce nausea), backed by 100,000+ patients and 14,000+ Trustpilot reviews. |
| Our Score | 7.9/10 | 7.3/10 |
| Headline Price | $188 first month, then $298/mo | from $165/mo |
| Medication Type | Brand | Compounded |
| Insurance Accepted | No | No |
| Best For | Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors | Budget-conscious users looking for the lowest monthly GLP-1 cost |
| Watch out for | Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable. | Available in 42 states, not all 50 (8 states are excluded). Check your state during signup before planning around PeterMD. |
| Ranking | #7 | #28 |
| Get started | Visit Hims | Visit PeterMD |
Pros & Cons Compared
Hims
Pros
- +Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
- +2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
- +Medication starts at $149/mo for Wegovy pill, Foundayo, and Ozempic pill; Wegovy or Ozempic pens start at $199 and Zepbound at $299. The required membership makes the lowest all-in path $188 in month one and $298/mo ongoing, and exact product or dose can cost more.
- +Polished app and web experience, among the best user interfaces in men's telehealth.
- +8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.
Cons
- −Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable.
- −Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026), significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
- −28% of Trustpilot reviews are 1-star, the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
- −Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
- −'Hims Oral Kit' is NOT a GLP-1, it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Do not confuse its $69 price with the current brand-name GLP-1 menu.
- −The $149 GLP-1 figures are medication-only. A required Weight Loss Membership costs $39 in month one and $149/mo ongoing, so a $149 medication path totals at least $188 initially and $298/mo after that.
- −Cash-pay only, Hims does not bill insurance, so an insured buyer may do better on a copay.
- −Generic high-volume support, large patient base means less personalized attention than smaller competitors.
PeterMD
Pros
- +Flat $165/mo at all dose levels, price doesn't increase as you titrate up to maintenance doses
- +100,000+ patient base with 4.9/5 Trustpilot rating from 14,000+ reviews, strong social proof
- +Semaglutide + B12 formulation helps reduce nausea, the most common GLP-1 side effect
- +Video consultations with physicians included, real face-to-face medical oversight
Cons
- −Available in 42 states, not all 50 (8 states are excluded). Check your state during signup before planning around PeterMD.
- −Not BBB accredited, and some documented complaints cite delayed medication fulfillment. Order refills ahead of your last dose rather than at the last minute.
- −PeterMD began as a testosterone replacement therapy platform; GLP-1 is an expansion, not the original core. The included video consultations give you a direct read on the clinical team.
Our Verdict
Hims edges out PeterMD with a score of 7.9/10 vs 7.3/10. Published pricing is not a like-for-like monthly comparison: Hims is $188 first month, then $298/mo; PeterMD is from $165/mo.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Hims and PeterMD.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Hims vs MangoRxfrom $299/mo
- Hims vs Oak Longevityfrom $119/mo
- Hims vs Telos RXpublished $99/mo; total not verified
- PeterMD vs Zealthyfrom $286/mo
- PeterMD vs Noom Med$79 first month, then $199/mo
- PeterMD vs WeightWatchers (Sequence)$74/mo membership + medication
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: Hims · 7.9/10